These products are not subject to the same pharmaceutical manufacturing standards, sterility testing, or third-party verification that a licensed 503A compounding pharmacy must meet
Here is a picture of my medicine
These commenters recommended that measure scores be adjusted to account for patient factors beyond the control of the facility such as age, education, surgery type, time between surgery and survey response, overall physical and mental health, health literacy, and language barriers
Scientific and Official Sources PubChem: BPC-157 identity, synonyms, molecular formula and mass Sikiric and colleagues: early published BPC-157 research ClinicalTrials.gov: PCO-02 BPC-157 safety and pharmacokinetics study Lee and colleagues: two-participant BPC-157 intravenous pilot study McGuire and colleagues: narrative review of BPC-157 evidence and risk World Anti-Doping Agency: 2026 Prohibited List MHRA: Borderline products and how to tell if a product is a medicine Human Medicines Regulations 2012: Regulation 279 United States FDA: safety risks associated with certain bulk substances, including BPC-157 United States FDA: BPC-157-related bulk-substance briefing document CAP Code Section 12: Medicines and health-related products Health and Safety Executive: UK REACH Health and Safety Executive: Safety Data Sheets and COSHH Health and Safety Executive: COSHH risk assessment Cox and colleagues: identification and analytical detection of BPC-157 in confiscated material
Anecdotal reports from research settings suggest enhanced outcomes compared to single-agent use, though controlled comparative studies remain limited
This requires either a caloric deficit or high activity levels that create energy demand
